Evidence map›Paper›PMID 37231075›Full record

Trial reportNature medicine2023

Normothermic machine perfusion versus static cold storage in donation after circulatory death kidney transplantation: a randomized controlled trial.

Sarah A Hosgood, Christopher J Callaghan, Colin H Wilson, Laura Smith, Joanne Mullings, Jennifer Mehew, Gabriel C Oniscu, Benedict L Phillips, Lucy Bates, Michael L Nicholson

2 registry-linked trialsOpen access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nature medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 83 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed, 4 pooled it
50.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06263023 active not recruitingnot on this mapstarted 2024, after this paper: background citation

An Observational Study of a Dedicated Preservation and Assessment Service to Optimize Organ Utilization for Hard-to-Place Kidneys

TypeobservationalSponsor34 Lives, PBCRan2024 to 2028Enrolled80ConditionsOrgan PreservationArmsSub-Normothermic Machine Preservation and Assessment
NCT07341516 enrolling by invitationnot on this mapstarted 2025, after this paper: background citation

Worldwide Assessment of Deceased Donor Kidney Utilization: Disparities, Temporal Trends, and Outcomes

TypeobservationalSponsorParis Translational Research Center for Organ TransplantationRan2025 to 2026Enrolled300,000ConditionsKidney Failure, Kidney Transplant, Deceased Donor Kidney Transplant
3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 4 syntheses or guidelines pooled it, 160 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Simultaneous Heart and Kidney Transplantation: A Systematic Review and Proportional Meta-Analysis of Its Characteristics and Long-Term Variables.Transplant international : official journal of the European Society for Organ Transplantation · 2024
    Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Sarah A HosgoodDepartment of Surgery, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. sh744@cam.ac.uk.ORCID 0000-0002-8039-143X
Christopher J CallaghanDepartment of Nephrology and Transplantation, Guy's Hospital, Guy's and St. Thomas' NHS Foundation Trust, London, UK.
Colin H WilsonFreeman Hospital, Institute of Transplantation, Newcastle upon Tyne Hospitals NHS Trust and Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
Laura SmithNHS Blood and Transplant (NHSBT) Clinical Trials Unit, NHSBT Stoke Gifford, Bristol, UK.
Joanne MullingsNHS Blood and Transplant (NHSBT) Clinical Trials Unit, NHSBT Stoke Gifford, Bristol, UK.
Jennifer MehewNHS Blood and Transplant (NHSBT) Clinical Trials Unit, NHSBT Stoke Gifford, Bristol, UK.
Gabriel C OniscuEdinburgh Transplant Centre, Royal Infirmary of Edinburgh, Edinburgh, UK.ORCID 0000-0003-1714-920X
Benedict L PhillipsDepartment of Nephrology and Transplantation, Guy's Hospital, Guy's and St. Thomas' NHS Foundation Trust, London, UK.ORCID 0000-0001-6608-7100
Lucy BatesFreeman Hospital, Institute of Transplantation, Newcastle upon Tyne Hospitals NHS Trust and Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
Michael L NicholsonDepartment of Surgery, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
NHS Blood and Transplant · GBFreeman Hospital · GBGuy's Hospital · GBUniversity of Cambridge · GBEdinburgh Royal Infirmary · GB

Funding

DH | National Institute for Health Research (NIHR) NIHR203312DH | National Institute for Health Research (NIHR) RG75628Kidney Research UK SP/MEKC/1/2014
6 · The paper itself

Abstract

Kidney transplantation is the optimal treatment for end-stage renal disease, but it is still severely limited by a lack of suitable organ donors. Kidneys from donation after circulatory death (DCD) donors have been used to increase transplant rates, but these organs are susceptible to cold ischemic injury in the storage period before transplantation, the clinical consequence of which is high rates of delayed graft function (DGF). Normothermic machine perfusion (NMP) is an emerging technique that circulates a warmed, oxygenated red-cell-based perfusate through the kidney to maintain near-physiological conditions. We conducted a randomized controlled trial to compare the outcome of DCD kidney transplants after conventional static cold storage (SCS) alone or SCS plus 1-h NMP. A total of 338 kidneys were randomly allocated to SCS (n = 168) or NMP (n = 170), and 277 kidneys were included in the final intention-to-treat analysis. The primary endpoint was DGF, defined as the requirement for dialysis in the first 7 d after transplant. The rate of DGF was 82 of 135 (60.7%) in NMP kidneys versus 83 of 142 (58.5%) in SCS kidneys (adjusted odds ratio (95% confidence interval) 1.13 (0.69-1.84); P = 0.624). NMP was not associated with any increase in transplant thrombosis, infectious complications or any other adverse events. A 1-h period of NMP at the end of SCS did not reduce the rate of DGF in DCD kidneys. NMP was demonstrated to be feasible, safe and suitable for clinical application. Trial registration number: ISRCTN15821205 .

Indexed as

Kidney TransplantationHumansKidneyOrgan PreservationPerfusionTissue Donors

Identifiers

PMID37231075
PMCPMC10287561
OpenAlexW4378212240

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.